Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy
Clinical Genetics · 2024
DOI: 10.1111/cge.14505 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Genetics, 2024. Verfasst von Flavie Ader und 14 weiteren Autor:innen. Beteiligte Einrichtung: APHP-Sorbonne Université-DMU BioGem-Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et cellulaire, Service de Biochimie Métaboliqu…. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Phenotype, Muscle Proteins, Protein Kinases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Fédération Française de Cardiologie.
Abstract (Originalsprache)
Biallelic disease‐causing variants in the ALPK3 gene were first identified in children presenting with a severe cardiomyopathy. More recently, it was shown that carriers of heterozygous ALPK3 null variants are at risk of developing hypertrophic cardiomyopathy (HCM) with an adult onset. Since the number of reported ALPK3 patients is small, the mutational spectrum and clinical data are not fully described. In this multi‐centric study, we described the molecular and clinical spectrum of a large cohort of ALPK3 patients. Genetic testing using targeted next generation sequencing was performed in 16 183 cardiomyopathy index cases. Thirty‐six patients carried at least one null ALPK3 variant. The five paediatric patients carried two ALPK3 variants, all presented an HCM phenotype with severe outcomes (one transplantation, one heart failure and one cardiac arrest). The 31 adult patients carried heterozygous variants and the main phenotype was HCM ( n = 26/31); including 15% ( n = 4) presented with an apical or a concentric form of hypertrophy. Reporting a large cohort of ALPK3 patients, this collaborative work confirmed a strong association with HCM and suggesting his screening in the context of idiopathic HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- APHP-Sorbonne Université-DMU BioGem-Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et cellulaire, Service de Biochimie Métabolique, APHP-Hôpital Universitaire Pitié Salpêtrière, Paris, France.
- INSERM UMRS1166 Équipe 1, ICAN Institute (institut de cardiométabolisme et nutrition), Paris, France.
- Université Paris Cité, UFR de Pharmacie, Paris, France.
- Laboratoire de Génétique Constitutionnelle, CHU d'Amiens, Amiens, France.
- UR4666 HEMATIM, Université de Picardie Jules Verne, Amiens, France.
- UF Pathologies Cardiaques Héréditaires, Service de Biochimie, Hospices Civils de Lyon, Bron, France.
ORCID-Profile: Flavie Ader, Alexandre Janin, Clarisse Billon, Gilles Millat, Pascale Richard
Förderung
- Fédération Française de Cardiologie
Zitieren
APA
Ader, F., Jedraszak, G., Janin, A., Billon, C., Buisson, N. R., Bloch, A., Bensalah, M., De Sandre-Giovannoli, A., Goudal, A., Marsili, L., Cazeneuve, C., Charron, P., Millat, G., Richard, P., & Cardiogen French Network of Molecular Biologists (2024). Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy. Clinical Genetics. https://doi.org/10.1111/cge.14505
Vancouver
Ader F, Jedraszak G, Janin A, Billon C, Buisson NR, Bloch A, et al. Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy. Clinical Genetics. 2024. doi:10.1111/cge.14505
BibTeX
@article{Ader2024,
author = {Ader, Flavie and Jedraszak, Guillaume and Janin, Alexandre and Billon, Clarisse and Buisson, Nathalie Roux and Bloch, Adrien and Bensalah, Meriem and De Sandre-Giovannoli, Anachiara and Goudal, Adeline and Marsili, Luisa and Cazeneuve, Cécile and Charron, Philippe and Millat, Gilles and Richard, Pascale and Cardiogen French Network of Molecular Biologists, Cardiogen French Network of Molecular Biologists},
title = {Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy},
journal = {Clinical Genetics},
year = {2024},
doi = {10.1111/cge.14505}
}
EUVIMED